Vaccination News Home Page

http://www.sciencedirect.com/science?_ob=IssueURL&_tockey=%23TOC%235188%232002%23999799999.8995%23368819%23FLA%23Volume_20,_Supplement_4,_(19_December_2002)&_auth=y&wchp=dGLbVzb-lSztA&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=e7895b0f3f9c9b2d27971ae8ed17b575

Go to ScienceDirect Home Skip Main Navigation Links
 Register or Login:   Password:     Athens Login 
HomeBrowse JournalsBrowse Abstract DatabasesBrowse Reference WorksMy AlertsMy Profile Help (Opens new window)
Issues
Vaccine
Copyright © 2002 Elsevier Science Ltd. All rights reserved

Volume 20, Supplement 4, (19 December 2002)
   
E-mail Articles
        Selected checked docs: display checked docs
1.
Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells––impact on vaccine strategies, Pages A23-A27
Pascale Jeannin, Giovanni Magistrelli, Liliane Goetsch, Jean-Francois Haeuw, Nathalie Thieblemont, Jean-Yves Bonnefoy and Yves Delneste
Abstract | Full Text + Links | PDF (71 K)
2.
Synthetic and natural non-live vectors: rationale for their clinical development in cancer vaccine protocols, Pages A32-A39
E. Tartour, F. Benchetrit, N. Haicheur, O. Adotevi and W. H. Fridman
Abstract | Full Text + Links | PDF (92 K)
3.
Apoptosis of immune cells in the tumor microenvironment and peripheral circulation of patients with cancer: implications for immunotherapy, Pages A46-A51
Theresa L. Whiteside
Abstract | Full Text + Links | PDF (181 K)
4.
Do not underestimate the power of antibodies––lessons from adoptive transfer of antibodies against HIV, Pages A61-A65
Flavia Ferrantelli, Robert A. Rasmussen, Regina Hofmann-Lehmann, Weidong Xu, Harold M. McClure and Ruth M. Ruprecht
Abstract | Full Text + Links | PDF (238 K)
5.
Co-immunization of rhesus macaques with plasmid vectors expressing IFN-small gamma, Greek, GM-CSF, and SIV antigens enhances anti-viral humoral immunity but does not affect viremia after challenge with highly pathogenic virus, Pages A69-A79
P. Lena, F. Villinger, L. Giavedoni, C. J. Miller, G. Rhodes and P. Luciw
Abstract | Full Text + Links | PDF (391 K)
6.
The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection, Pages A80-A82
Luca G. Guidotti
Abstract | Full Text + Links | PDF (46 K)
7.
Towards immunotherapy for chronic hepatitis B virus infections, Pages A83-A88
M. -L. Michel
Abstract | Full Text + Links | PDF (70 K)
8.
Immune intervention strategies for HIV-1 infection of humans in the SIV macaque model, Pages A52-A60
Genoveffa Franchini, Janos Nacsa, Zdenek Hel and Elzbieta Tryniszewska
Abstract | Full Text + Links | PDF (218 K)
9.
Tumor-derived exosomes: a new source of tumor rejection antigens, Pages A28-A31
F. André, N. E. C. Schartz, N. Chaput, C. Flament, G. Raposo, S. Amigorena, E. Angevin and L. Zitvogel
Abstract | Full Text + Links | PDF (54 K)
10.
Therapeutic cancer vaccines based on molecularly defined human tumor antigens, Pages A2-A7
Pedro Romero, Mikael Pittet, Valerie Dutoit, Alfred Zippelius, Danielle Liénard, Ferdy Lejeune, Philippe Guillaume, Donata Rimoldi, Danila Valmori, Daniel E. Speiser and Jean-Charles Cerottini
Abstract | Full Text + Links | PDF (73 K)
11.
A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy, Pages A8-A22
Andrew W. Lee, Tuan Truong, Kara Bickham, Jean-Francois Fonteneau, Marie Larsson, Ida Da Silva, Selin Somersan, Elaine K. Thomas and Nina Bhardwaj
Abstract | Full Text + Links | PDF (566 K)
12.
HLA class I antigen loss, tumor immune escape and immune selection, Pages A40-A45
Michael Campoli, Chien-Chung Chang and Soldano Ferrone
Abstract | Full Text + Links | PDF (235 K)
13.
Viral evolution and challenges in the development of HIV vaccines, Pages A66-A68
Dan H. Barouch and Norman L. Letvin
Abstract | Full Text + Links | PDF (45 K)
14.
Therapeutic vaccines against HIV and cancers, Page A1
Marc Girard, Betty Dodet and Marissa Vicari
Abstract | Full Text + Links | PDF (23 K)
15.
Editorial Board/Aims and scope, Page CO2

PDF (42 K)


 

E-mail Articles
Issues
HomeBrowse JournalsBrowse Abstract DatabasesBrowse Reference WorksMy AlertsMy Profile   Help (Opens new window)


 

Send feedback to ScienceDirect
Software and compilation © 2002 ScienceDirect. All rights reserved.
ScienceDirect® is an Elsevier Science B.V. registered trademark.


Your use of this service is governed by Terms and Conditions. Please review our Privacy Policy for details on how we protect information that you supply.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.